Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for COVID-19 Symptom Attenuation
NCT05074121Phase 2Unknown
- Sponsor
- Cambridge Health Alliance
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in coronavirus disease 2019 (COVID-19), sponsored by Cambridge Health Alliance. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05074121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05074121.